Literature DB >> 19582474

Level of education and the risk of lymphoma in the European prospective investigation into cancer and nutrition.

Silke Hermann1, Sabine Rohrmann, Jakob Linseisen, Alexandra Nieters, Aneire Khan, Valentina Gallo, Kim Overvad, Anne Tjønneland, Ole Raaschou-Nielsen, Manuela M Bergmann, Heiner Boeing, Nikolaus Becker, Rudolf Kaaks, H Bas Bueno-de-Mesquita, Anne M May, Roel C H Vermeulen, Sheila Bingham, Kay-Tee Khaw, Timothy J Key, Ruth C Travis, Antonia Trichopoulou, Christina Georgila, Dimitra Triantafylou, Egidio Celentano, Vittorio Krogh, Giovanna Masala, Rosario Tumino, Antonio Agudo, Jone M Altzibar, Eva Ardanaz, Carmen Martínez-García, Marcial Vicente Argüelles Suárez, Maria José Tormo, Tonje Braaten, Eiliv Lund, Jonas Manjer, Sophia Zackrisson, Göran Hallmans, Beatrice Malmer, Paolo Boffetta, Paul Brennan, Nadia Slimani, Paolo Vineis, Elio Riboli.   

Abstract

INTRODUCTION: Lymphomas belong to the few cancer sites with increasing incidence over past decades, and only a few risk factors have been established. We explored the association between education and the incidence of lymphoma in the prospective EPIC study.
MATERIALS AND METHODS: Within 3,567,410 person-years of follow-up, 1,319 lymphoma cases [1,253 non-Hodgkin lymphomas (NHL) and 66 Hodgkin lymphomas (HL)] were identified. Cox proportional hazard regression was used to examine the association between highest educational level (primary school or less, technical/professional school, secondary school, university) and lymphoma risk.
RESULTS: Overall, no consistent associations between educational level and lymphoma risk were observed; however, associations were found for sub-groups of the cohort. We observed a higher risk of B-NHL (HR = 1.31, 95% CI = 1.02–1.68; n = 583) in women with the highest education level (university) but not in men. Concerning sub-classes of B-NHL, a positive association between education and risk of B cell chronic lymphatic leukaemia (BCLL) was observed only in women. In both genders, the risk of diffuse large B cell lymphoma (DLBCL) was significantly lower for subjects with university degree (HR = 0.46, 95% CI = 0.27–0.79) versus lowest educational level. No association was found for HL.
CONCLUSION: We could not confirm an overall consistent association of education and risk of HL or NHL in this large prospective study; although, education was positively related to the incidence of BCLL and B-NHL (in women) but inversely to incidence of DLBCL. Due to limited number of cases in sub-classes and the large number of comparisons, the possibility of chance findings can not be excluded.

Entities:  

Mesh:

Year:  2010        PMID: 19582474     DOI: 10.1007/s00432-009-0638-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  17 in total

1.  Socioeconomic status and multiple myeloma among US blacks and whites.

Authors:  D Baris; L M Brown; D T Silverman; R Hayes; R N Hoover; G M Swanson; M Dosemeci; A G Schwartz; J M Liff; J B Schoenberg; L M Pottern; J Lubin; R S Greenberg; J F Fraumeni
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

Review 2.  Measures of health inequalities: part 1.

Authors:  Enrique Regidor
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

3.  Recent trends and future projections of lymphoid neoplasms--a Bayesian age-period-cohort analysis.

Authors:  I Bray; P Brennan; P Boffetta
Journal:  Cancer Causes Control       Date:  2001-11       Impact factor: 2.506

Review 4.  Multiple myeloma: a review of the epidemiologic literature.

Authors:  Dominik D Alexander; Pamela J Mink; Hans-Olov Adami; Philip Cole; Jack S Mandel; Martin M Oken; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2007       Impact factor: 7.396

5.  Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: are the changes real?

Authors:  R Velez; V Beral; J Cuzick
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

Review 6.  The epidemiology of non-Hodgkin's lymphoma.

Authors:  Susan G Fisher; Richard I Fisher
Journal:  Oncogene       Date:  2004-08-23       Impact factor: 9.867

7.  Multiple myeloma in the United States, 1950--1975.

Authors:  W A Blattner; A Blair; T J Mason
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

8.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

9.  Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms.

Authors:  E V Willett; C F Skibola; P Adamson; D R Skibola; G J Morgan; M T Smith; E Roman
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

10.  Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma.

Authors:  Christine F Skibola; Elizabeth A Holly; Matthew S Forrest; Alan Hubbard; Paige M Bracci; Danica R Skibola; Christine Hegedus; Martyn T Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254

View more
  1 in total

1.  Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.

Authors:  Fatemeh Saberi Hosnijeh; Delphine Casabonne; Alexandra Nieters; Marta Solans; Sabine Naudin; Pietro Ferrari; James D Mckay; Yolanda Benavente; Elisabete Weiderpass; Heinz Freisling; Gianluca Severi; Marie-Christine Boutron Ruault; Caroline Besson; Claudia Agnoli; Giovanna Masala; Carlotta Sacerdote; Rosario Tumino; José María Huerta; Pilar Amiano; Miguel Rodriguez-Barranco; Catalina Bonet; Aurelio Barricarte; Sofia Christakoudi; Anika Knuppel; Bas Bueno-de-Mesquita; Matthias B Schulze; Rudolf Kaaks; Federico Canzian; Florentin Späth; Mats Jerkeman; Charlotta Rylander; Anne Tjønneland; Anja Olsen; Kristin Benjaminsen Borch; Roel Vermeulen
Journal:  Int J Cancer       Date:  2020-11-12       Impact factor: 7.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.